Bulletin 2009/07 - European Patent Office
13.12.2012 • Views
Share Embed Flag

Bulletin 2009/07 - European Patent Office

Bulletin 2009/07 - European Patent Office

Bulletin 2009/07 - European Patent Office

SHOW MORE
SHOW LESS
ePAPER READ
DOWNLOAD ePAPER
application.epo.org

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

START NOW

(A61K) I.1(1)<br />

(71) Ibd Column Therapies International AB, Mem<br />

Slott, 61492 Söderköping, SE<br />

(72) THÖRN, Magnus, S-75226 Uppsala, SE<br />

WINQVIST, Ola, S-756 53 Uppsala, SE<br />

(74) White, Nina Louise, Boult Wade Tennant<br />

Verulam Gardens 70 Gray's Inn Road,<br />

London WC1X 8BT, GB<br />

(51) A61K 39/395 (11) 2 021 026 A1*<br />

A61P 27/02<br />

(25) En (26) En<br />

(21) <strong>07</strong>755421.0 (22) 12.04.20<strong>07</strong><br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC MT NL PL PT<br />

RO SE SI SK TR<br />

AL BA HR MK RS<br />

(86) US 20<strong>07</strong>/009139 12.04.20<strong>07</strong><br />

(87) WO 20<strong>07</strong>/120828 20<strong>07</strong>/43 25.10.20<strong>07</strong><br />

(30) 14.04.2006 US 792293 P<br />

12.05.2006 US 747134 P<br />

(54) • VERWENDUNG VON IL-I-ANTIKÖRPERN<br />

ZUR BEHANDLUNG VON AUGENLEIDEN<br />

• USE OF IL-I ANTIBODIES FOR TREATING<br />

OPHTHALMIC DISORDERS<br />

• UTILISATION D'ANTICORPS ANTI-IL-1<br />

POUR LE TRAITEMENT DE TROUBLES<br />

OPHTALMIQUES<br />

(71) NOVARTIS AG, Lichtstrasse 35, 4056 Basel,<br />

CH<br />

Novartis Pharma GmbH, Brunner Strasse 59,<br />

1230 Vienna, AT<br />

(84) AT<br />

(72) YOO, Dana, Sue, Boston, Massachusetts<br />

02134, US<br />

NEUNER-JEHLE, Martin, CH-4118 Rodersdorf,<br />

CH<br />

SCASSELLATI-SFORZOLINI, Baldo, Far Hills,<br />

New Jersey <strong>07</strong>931, US<br />

KEATING, Mark Taylor, Weston, Massachusetts<br />

02493, US<br />

MARKABI, Olivier Sabri, Summit, New Jersey<br />

<strong>07</strong>901, US<br />

(74) Kassow, Anders, et al, Novartis Pharma AG<br />

<strong>Patent</strong> Department, 4002 Basel, CH<br />

(51) A61K 39/395 (11) 2 021 027 A2*<br />

(25) En (26) En<br />

(21) <strong>07</strong>783226.9 (22) 03.05.20<strong>07</strong><br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC MT NL PL PT<br />

RO SE SI SK TR<br />

AL BA HR MK RS<br />

(86) US 20<strong>07</strong>/068174 03.05.20<strong>07</strong><br />

(87) WO 20<strong>07</strong>/131129 20<strong>07</strong>/46 15.11.20<strong>07</strong><br />

(88) 27.11.2008<br />

(30) 03.05.2006 US 797286 P<br />

(54) • IMMUNGLOBULIN-ASSOZIIERTE ZELLO-<br />

BERFLÄCHENDETERMINANTEN BEI DER<br />

BEHANDLUNG VON B-ZELL-ERKRANKUN-<br />

GEN<br />

• IMMUNOGLOBULIN ASSOCIATED CELL-<br />

SURFACE DETERMINANTS IN THE<br />

TREATMENT OF B-CELL DISORDERS<br />

• DÉTERMINANTS DE SURFACE CELLU-<br />

LAIRE ASSOCIÉS À L'IMMUNOGLOBU-<br />

LINE DANS LE TRAITEMENT DE<br />

TROUBLES DES LYMPHOCYTES B<br />

(71) Guthrie Foundation For Education&Research,<br />

Guthrie Square, Sayre PA 18840, US<br />

(72) WELT, Sydney, Armonk, NY 10504, US<br />

KOSTYAL, David, A., Sayre, PA 18840, US<br />

(74) Irvine, Jonquil Claire, Marks & Clerk 4220<br />

Nash Court, Oxford Business Park South<br />

Oxford OX4 2RU, GB<br />

(51) A61K 39/395 (11) 2 021 028 A2*<br />

A61K 31/506 A61P 7/10<br />

(25) En (26) En<br />

Europäisches <strong>Patent</strong>blatt<br />

<strong>European</strong> <strong>Patent</strong> <strong>Bulletin</strong><br />

<strong>Bulletin</strong> européen des brevets<br />

(21) <strong>07</strong>797242.0 (22) 17.04.20<strong>07</strong><br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC MT NL PL PT<br />

RO SE SI SK TR<br />

AL BA HR MK RS<br />

(86) US 20<strong>07</strong>/066804 17.04.20<strong>07</strong><br />

(87) WO 20<strong>07</strong>/124308 20<strong>07</strong>/44 01.11.20<strong>07</strong><br />

(88) 21.02.2008<br />

(30) 17.04.2006 US 792318 P<br />

06.10.2006 US 828506 P<br />

(54) • VERFAHREN UND ZUSAMMENSETZUN-<br />

GEN ZUR MODULATION DER BLUT-NER-<br />

VEN-SCHRANKE<br />

• METHODS AND COMPOSITIONS FOR<br />

MODULATION OF BLOOD-NEURAL BAR-<br />

RIER<br />

• MÉTHODES ET COMPOSITIONS POUR<br />

MODULER LA BARRIÈRE HÉMATO-NEU-<br />

RALE<br />

(71) LUDWIG INSTITUTE FOR CANCER<br />

RESEARCH, 605 Third Avenue, New York,<br />

New York 10158, US<br />

(72) ERIKSSON, Ulf, S-171 77 Stockholm, SE<br />

LAWRENCE, Daniel, Ann Arbor, MI 48109-<br />

0644, US<br />

SU, Enming, Joe, Ann Arbor, MI 48103, US<br />

STRICKLAND, Dudley, Brookville, MD<br />

20833, US<br />

YEPPES, Manuel, Atlanta, GA 30322, US<br />

FREDRIKSSON, Linda, S-129 39 Hagersten,<br />

SE<br />

(74) Williams, Richard Andrew Norman, et al,<br />

Harrison Goddard Foote 40- 43 Chancery<br />

Lane, London WC2A 1JA, GB<br />

(51) A61K 39/395 (11) 2 021 029 A2*<br />

A61P 43/00 C<strong>07</strong>H 21/04<br />

C<strong>07</strong>K 16/18 C12N 15/00<br />

C12N 5/06 C12P 21/04<br />

G01N 33/564<br />

(25) En (26) En<br />

(21) <strong>07</strong>873826.7 (22) 25.05.20<strong>07</strong><br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC MT NL PL PT<br />

RO SE SI SK TR<br />

AL BA HR MK RS<br />

(86) US 20<strong>07</strong>/069767 25.05.20<strong>07</strong><br />

(87) WO 2008/105886 2008/36 04.09.2008<br />

(30) 26.05.2006 US 809116 P<br />

23.06.2006 US 816126 P<br />

(54) • HUMANISIERTE FC-RIIB-SPEZIFISCHE<br />

ANTIKÖRPER UND VERFAHREN ZU IHRER<br />

ANWENDUNG<br />

• HUMANIZED FC RIIB-SPECIFIC ANTIBO-<br />

DIES AND METHODS OF USE THEREOF<br />

• ANTICORPS SPÉCIFIQUES FCGRIIB<br />

HUMANISÉS, ET LEURS PROCÉDÉS<br />

D'UTILISATION<br />

(71) MacroGenics, Inc., 1500 East Gude Drive,<br />

Rockville, MD 20850-53<strong>07</strong>, US<br />

(72) JOHNSON, Leslie S., Darnestown, Maryland<br />

20874, US<br />

HUANG, Ling, Bethesda, Maryland 20817,<br />

US<br />

(74) Ede, Eric, Murgitroyd & Company 165-169<br />

Scotland Street, Glasgow G5 8PL, GB<br />

A61K 39/395 → (51) A61K 39/00<br />

A61K 39/395 → (51) A61K 47/12<br />

A61K 39/395 → (51) C<strong>07</strong>K 16/28<br />

A61K 39/40 → (51) A61K 39/00<br />

A61K 45/06 → (51) A61K 31/40<br />

43<br />

Anmeldungen<br />

Applications<br />

Demandes (<strong>07</strong>/<strong>2009</strong>) 11.02.<strong>2009</strong><br />

A61K 47/06 → (51) A61K 39/385<br />

A61K 47/10 → (51) A61K 9/00<br />

(51) A61K 47/12 (11) 2 021 030 A2*<br />

A61K 47/26 A61K 47/34<br />

A61K 9/08 A61K 39/395<br />

(25) En (26) En<br />

(21) <strong>07</strong>755818.7 (22) 19.04.20<strong>07</strong><br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC MT NL PL PT<br />

RO SE SI SK TR<br />

AL BA HR MK RS<br />

(86) US 20<strong>07</strong>/009700 19.04.20<strong>07</strong><br />

(87) WO 20<strong>07</strong>/124082 20<strong>07</strong>/44 01.11.20<strong>07</strong><br />

(30) 21.04.2006 US 794201 P<br />

21.12.2006 US 876726 P<br />

(54) • PUFFERMITTEL FÜR BIOPHARMAZEUTI-<br />

SCHE FORMULIERUNGEN<br />

• BUFFERING AGENTS FOR BIOPHARMA-<br />

CEUTICAL FORMULATIONS<br />

• AGENTS DE TAMPONNAGE POUR FOR-<br />

MULATIONS BIOPHARMACEUTIQUES<br />

(71) Amgen, Inc., One Amgen Center Drive Mailstop<br />

27-4-A, Thousands Oaks, CA 91320-<br />

1789, US<br />

(72) GOKARN, Yatin, Thousand Oaks, CA 91362,<br />

US<br />

(74) Hill, Justin John, et al, McDermott Will &<br />

Emery UK LLP 7 Bishopsgate, London EC2N<br />

3AR, GB<br />

A61K 47/26 → (51) A61K 47/12<br />

(51) A61K 47/32 (11) 2 021 031 A1*<br />

A61K 8/02 A61K 8/73<br />

A61K 8/81 A61K 9/70<br />

A61K 47/38 A61Q 19/00<br />

(25) En (26) En<br />

(21) <strong>07</strong>744839.7 (22) 31.05.20<strong>07</strong><br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC MT NL PL PT<br />

RO SE SI SK TR<br />

AL BA HR MK RS<br />

(86) JP 20<strong>07</strong>/061500 31.05.20<strong>07</strong><br />

(87) WO 20<strong>07</strong>/142280 20<strong>07</strong>/50 13.12.20<strong>07</strong><br />

(30) 31.05.2006 JP 2006151373<br />

(54) • HYDROGEL-PLATTE UND HERSTEL-<br />

LUNGSVERFAHREN DAFÜR<br />

• HYDROGEL SHEET AND PRODUCTION<br />

METHOD THEREOF<br />

• FEUILLE D'HYDROGEL ET SON PROCÉDÉ<br />

DE FABRICATION<br />

(71) Shin-Etsu Chemical Co., Ltd., 6-1, Ohtemachi<br />

2-chome Chiyoda-ku, Tokyo 100-0004,<br />

JP<br />

(72) YAMASHITA, Makoto, Tokorozawa-shi, Saitama<br />

359-0021, JP<br />

MARUYAMA, Naosuke, Joetsu-shi, Niigata<br />

942-8601, JP<br />

HAYAKAWA, Kazuhisa, Joetsu-shi, Niigata<br />

942-8601, JP<br />

(74) Harrison Goddard Foote, Orlando House 11c<br />

Compstall Road, Marple Bridge Stockport<br />

SK6 5HH, GB<br />

A61K 47/34 → (51) A61K 47/12<br />

A61K 47/38 → (51) A61K 47/32<br />

(51) A61K 47/48 (11) 2 021 032 A1*<br />

(25) En (26) En<br />

(21) <strong>07</strong>725487.8 (22) 23.05.20<strong>07</strong><br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC MT NL PL PT<br />

RO SE SI SK TR<br />

AL BA HR MK RS

logo

products

Resources

Company

Terms of service
Privacy policy
Cookie policy
Cookie settings
Imprint
Change language
Made with love in Switzerland
© 2024 Yumpu.com all rights reserved

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!